Eye Movement Testing for Diagnosing Encephalopathy in Patients With Liver Disease

Stopped early

Conditions studied: Cirrhosis, Hepatic Encephalopathy

In brief

This study involves utilizing a noninvasive computer application (Neurofit) that performs oculometric assessment of dynamic visual processing in patients with liver cirrhosis to see if the presence of advance liver disease influences eye movement metrics.

Key facts

Study ID

NCT04940416

Run by

Stanford University

People needed

48

Starts

2017-08-31

Expected to finish

2021-06-17

Last updated by the study team

2021-06-25

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients with cirrhosis with clinical appointments in the pretransplant liver clinic
• Patients in the general gastroenterology clinic without a diagnosis of cirrhosis (controls)

You may not qualify if…

• Individuals <18 years
• cirrhotic patients with hepatocellular cancer
• individuals with uncontrolled neuropsychiatric illnesses or overt hepatic encephalopathy
• ongoing alcohol or illicit substance use
• non-English speakers, as the language barrier may impact psychometric test results

Where it is running

• Stanford University School of Medicine — Redwood City, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.